Riskpilot← Back to searchSign inGet full accessSARSIA DEVELOPMENT AS
ASActiveOrg 986382178Bønesberget 84, 5153 BønesActivities of money market and non-money market investments funds · NACE 6431Est. 20040 employeeswww.sarsia.com
Revenue 2024
NOK 0
EBITDA margin
—
+2% vs 2023
Equity ratio
-437.4%
Financial strength
Net profit 2024
NOK -10,6M
+3% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -679K | +2% |
| Net profit | NOK -10,6M | +3% |
| Total assets | NOK 1,2M | -89% |
| Equity | NOK -5,2M | -198% |
| Employees | 0 | — |
Legal name
SARSIA DEVELOPMENT AS
Org number
986382178
Legal form
Aksjeselskap
NACE code
6431 · Activities of money market and non-money market investments funds
Founded
6. januar 2004
Share capital
NOK 1 562 762
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Styrets leder alene.
Company purpose
Investeringsvirksomhet innen private equity og venture kapital. Selskapet vil normalt investere i aksjer og konvertible lån, men kan også investere i tegningsretter, opsjoner, derivater og andre finansielle instrumenter i porteføljeselskaper hvor selskapet tidligere har eller samtidig investerer i aksjer eller konvertible lån. Rente og valutaderivater kan kun benyttes dersom det anses nødvendig for å redusere selskapets risiko knyttet til disse forhold. Selskapet vil inneha en portefølje av aksjer i enkeltstående selskaper og eierandeler i investeringsfond. Selskapet skal videreutvikle og forvalte porteføljen av aksjer i enkelte selskaper og fondsandeler, herunder foreta oppfølgingsinvesteringer i disse. Selskapet skal også kunne investere i nye virksomheter. Selskapet vil primært investere i selskaper hvis hovedvirksomhet er i en tidlig fase eller vektfase. For å søke å oppnå sitt formål skal selskapet blant annet forvalte og utvikle selskapets investeringer med den målsetning at verdien av disse økes, derfor det er ønskelig for å sikre verdiutvikling i porteføljeselskapene, beslutte oppfølgingsinvesteringer i porteføljeselskapene, beslutte salg/realisering av eierandelene i porteføljeselskapene på en for selskapets best mulig måte med målsetning og endelig avvikling innen 2015.
Address
Bønesberget 84, 5153 Bønes
Website
www.sarsia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −154 | −171 | −205 | −205 | −205 | −205 | −205 | −205 | −205 | −205 | −66 | −68 | −137 | −251 | −217 |
| EBITDA | −504 | −2 867 | −3 334 | −2 889 | −2 862 | −2 891 | −1 773 | −640 | −648 | −692 | −627 | −2 116 | −508 | −1 841 | −692 | −679 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −504 | −2 867 | −3 334 | −2 889 | −2 862 | −2 891 | −1 773 | −640 | −648 | −692 | −627 | −2 116 | −508 | −1 841 | −692 | −679 |
| Net financials | −238 | −961 | 495 | −2 702 | 3 098 | −2 969 | −42 | −6 122 | −7 072 | 774 | 2 742 | 16 408 | 1 043 | 1 882 | −10 166 | −9 903 |
| Profit before tax | −742 | −3 828 | −2 840 | −5 591 | 236 | −5 861 | −1 815 | −6 761 | −7 720 | 82 | 2 115 | 14 292 | 535 | 41 | −10 858 | −10 582 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −742 | −3 828 | −2 840 | −5 591 | 236 | −5 861 | −1 815 | −6 761 | −7 720 | 82 | 2 115 | 14 292 | 535 | 41 | −10 858 | −10 582 |
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 40 814 | 36 767 | 67 371 | 61 780 | 62 016 | 56 173 | 56 341 | 49 579 | 41 866 | 42 133 | 41 638 | 23 603 | 17 741 | 17 391 | 11 278 | 1 195 |
| Equity | 40 594 | 36 766 | 67 371 | 61 779 | 62 016 | 56 155 | 56 340 | 49 578 | 41 859 | 42 058 | 34 932 | 18 268 | 16 172 | 16 213 | 5 355 | −5 227 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 745 | 5 244 |
| Short-term debt | 220 | 1 | 0 | 1 | 0 | 18 | 1 | 1 | 7 | 75 | 6 706 | 5 335 | 1 570 | 1 178 | 1 178 | 1 178 |
| Total debt | 220 | 1 | 0 | 1 | 0 | 18 | 1 | 1 | 7 | 75 | 6 706 | 5 335 | 1 570 | 1 178 | 5 923 | 6 422 |
EBITDA margin
-67910500.0%
This company
15.8%
Market median
-429813391% vs market
20092024
Equity ratio
-437.4%
This company
38.2%
Market median
-1245% vs market
20092024
Return on equity
-1058237400.0%
This company
18.4%
Market median
-5751290317% vs market
20092024
Net profit margin
-1058237400.0%
This company
8.1%
Market median
-13064659359% vs market
20092024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20092024
Debt / equity
1.23×
This company
0.62×
Market median
-98% vs market
20092024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HJ Chief Executive Officer | Chief Executive Officer | 2008 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Stiftelsen Universitetsforskning Bergen | Company | 28.6% | 28.6% | 2023 |
Meteva As | Company | 20.7% | 20.7% | 2023 |
L. Meltzers Universitetsstiftelse | Company | 18.8% | 18.8% | 2023 |
Sparebanken Norge | Company | 9.9% | 9.9% | 2023 |
Nordea Alternative Strategies Fund | Company | 7.5% | 7.5% | 2023 |
Nordea Liv Forsikring As | Company | 7.5% | 7.5% | 2022 |
Hannibal Invest As | Company | 5.8% | 5.8% | 2023 |
Orkla Asa | Company | 2.2% | 2.2% | 2023 |
Dnb Livsforsikring As | Company | 1.9% | 1.9% | 2023 |
M A Wick As | Company | 1.6% | 1.6% | 2023 |
Gnist Holding As | Company | 1.6% | 1.6% | 2023 |
Gc Rieber Fortuna As | Company | 1.1% | 1.1% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SARSIA DEVELOPMENT AS 
Deepx Health AsBoard members of SARSIA DEVELOPMENT AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Johan Hekland | Chief Executive Officer | 0 companies |
| Marit Iren Austgulen Wick | Board of Directors | 0 companies |
| Sveinung Hole | Chairman | 0 companies |
| Kirsti Robertsen Aarøen | Board of Directors | 0 companies |
| Egil Hermann Sjursen | Chairman | 0 companies |